Allergy testing and treatment company Nectar Life Sciences announced the opening of the Nectar Allergy Center in New York, its first brick-and-mortar clinic, to expand its virtual care platform to a hybrid model.
Nectar, which launched earlier this year, offers at-home testing kits. Individuals can self-test for indoor or outdoor allergies and send their samples to Nectar for results.
Testers...
Allergy testing and treatment company Nectar raised $16.5 million in a Series A funding round led by Harmony Partners, bringing its total equity raise to more than $24 million.
The company's founding partners, Juxtapose and Obvious Ventures, also participated in the round — Obvious Ventures co-built Nectar with the company's current CEO and former AncestryDNA executive Kenneth Chahine.
WHAT THEY...